Valuation: QuidelOrtho Corporation

Market Cap 1.13B 981M 911M 841M 1.58B 108B 1.61B 10.79B 4.22B 53.58B 4.24B 4.15B 180B P/E 2026 *
-10.4x
P/E 2027 * -104x
Enterprise Value 3.5B 3.04B 2.82B 2.6B 4.9B 334B 4.99B 33.41B 13.08B 166B 13.14B 12.85B 558B EV / Sales 2026 *
1.29x
EV / Sales 2027 * 1.23x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+0.42%
1 week-0.06%
Current month-5.40%
1 month-5.40%
3 months+34.72%
6 months-39.01%
Current year-41.98%
1 week 16.13
Extreme 16.13
17.51
1 month 15.49
Extreme 15.49
19.03
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
87.56
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%-0.06%-31.78%-80.98% 1.13B
+1.24%+1.99%+20.18%-39.94% 15.89B
-3.49%-5.26%-0.23%+92.47% 1.7B
-0.29%+3.68%-37.98%+14.92% 998M
-0.46%+2.35%-46.92%-53.27% 646M
+2.08%+6.38%-46.41%-55.48% 538M
+1.10%+3.26%+48.59%-51.97% 467M
-0.73%+1.16%-53.61%-62.09% 377M
+0.27%+6.00%-15.01%-32.39% 371M
+0.53%+7.45%+12.19%+19.94% 313M
Average +0.07%+3.48%-15.10%-24.88% 2.24B
Weighted average by Cap. +0.68%+2.19%+8.56%-29.97%

Financials

2026 *2027 *
Net sales 2.71B 2.35B 2.18B 2.01B 3.79B 258B 3.86B 25.83B 10.12B 128B 10.16B 9.94B 431B 2.78B 2.41B 2.24B 2.07B 3.89B 265B 3.96B 26.53B 10.39B 132B 10.43B 10.21B 443B
Net income -156M -135M -126M -116M -218M -14.88B -222M -1.49B -583M -7.39B -585M -572M -24.85B -81.93M -71.17M -66.09M -60.95M -115M -7.82B -117M -782M -306M -3.88B -308M -301M -13.06B
Net Debt 2.37B 2.06B 1.91B 1.76B 3.32B 226B 3.38B 22.62B 8.86B 112B 8.9B 8.7B 378B 2.3B 2B 1.85B 1.71B 3.22B 219B 3.28B 21.95B 8.59B 109B 8.63B 8.44B 367B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-30 US$16.57 +0.42% 1,216,768
26-07-29 US$16.50 -1.02% 1,188,025
26-07-28 US$16.67 -0.95% 989,723
26-07-27 US$16.83 +4.86% 1,057,029
26-07-24 US$16.05 -3.20% 913,043
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
16.57USD
Average target price
21.33USD
Spread / Average Target
+28.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock